Edwards Lifesciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EW and other ETFs, options, and stocks.

About EW

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. 

CEO
Bernard J. Zovighian
CEOBernard J. Zovighian
Employees
16,000
Employees16,000
Headquarters
Irvine, California
HeadquartersIrvine, California
Founded
1958
Founded1958
Employees
16,000
Employees16,000

EW Key Statistics

Market cap
51.33B
Market cap51.33B
Price-Earnings ratio
53.46
Price-Earnings ratio53.46
Dividend yield
—
Dividend yield—
Average volume
3.39M
Average volume3.39M
High today
$91.05
High today$91.05
Low today
$88.97
Low today$88.97
Open price
$90.11
Open price$90.11
Volume
3.10M
Volume3.10M
52 Week high
$96.29
52 Week high$96.29
52 Week low
$74.66
52 Week low$74.66

Stock Snapshot

Edwards Lifesciences(EW) stock is priced at $89.07, giving the company a market capitalization of 51.33B. It carries a P/E multiple of 53.46.

On 2026-10-23, Edwards Lifesciences(EW) stock moved within a range of $88.97 to $91.05. With shares now at $89.07, the stock is trading +0.1% above its intraday low and -2.2% below the session's peak.

Trading volume for Edwards Lifesciences(EW) stock has reached 3.1M, versus its average volume of 3.39M.

The stock's 52-week range extends from a low of $74.66 to a high of $96.29.

The stock's 52-week range extends from a low of $74.66 to a high of $96.29.

EW News

Simply Wall St 1d
Is Edwards Lifesciences Undervalued After FDA Approvals For Its PASCAL Valve Systems?

Edwards Lifesciences (EW) just received FDA approvals for its PASCAL Precision tricuspid repair system and PASCAL Ace with Capture Clarity, expanding its presen...

Is Edwards Lifesciences Undervalued After FDA Approvals For Its PASCAL Valve Systems?
TipRanks 2d
Edwards Lifesciences announces U.S. FDA approval of PASCAL Precision

Edwards Lifesciences (EW) announced that the U.S. Food and Drug Administration, FDA, has approved its PASCAL Precision system for tricuspid valve repair. The sy...

Analyst ratings

77%

of 31 ratings
Buy
77.4%
Hold
22.6%
Sell
0%

People also own

Based on the portfolios of people who own EW. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.